Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-02

Clinical Trial Update: Diabetic Retinopathy: Effects of Melatonin Treatment on Visual Functions and Circadian Rhythm [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating melatonin treatment for diabetic retinopathy and its effects on visual function and circadian rhythm has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)

Snippet

Sponsor: Glostrup University Hospital, Copenhagen | Conditions: Diabetic Retinopathy, Melatonin | Phase 3 | Status: COMPLETED